On 22 Aug Ind For Neuromyelitis Optica Spectrum Disorder For Sn1011 Was Approved By Nmpa
23/08/2022 11:53
SinoMab BioScience Ltd 3681.HK :
* SINOMAB BIOSCIENCE LTD - ON 22 AUG IND FOR NEUROMYELITIS
OPTICA
SPECTRUM DISORDER FOR SN1011 WAS APPROVED BY NMPA
Source text for Eikon: ID:
Further company coverage: 3681.HK
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience